These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26125077)

  • 1. New Strategies to Address Critical Challenges.
    Holbrook S
    J Nucl Med Technol; 2014 Jun; 42(2):10A. PubMed ID: 26125077
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality and value of nuclear medicine and molecular imaging: the impact of health-care reform.
    Mitchell KR; Bunning SK
    J Nucl Med Technol; 2013 Mar; 41(1):3-8. PubMed ID: 23463864
    [No Abstract]   [Full Text] [Related]  

  • 3. Advocating for appropriate and adequate reimbursement.
    Dillehay G
    J Nucl Med; 2013 Sep; 54(9):20N. PubMed ID: 24003172
    [No Abstract]   [Full Text] [Related]  

  • 4. Breaking an unhelpful circle, where innovation and regularia delay clinical practice for patient benefit.
    Ell P; Carrio I; Chiti A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1397-1398. PubMed ID: 30944948
    [No Abstract]   [Full Text] [Related]  

  • 5. SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
    Schwarz SW
    J Nucl Med; 2017 Jan; 58(1):20N. PubMed ID: 28062714
    [No Abstract]   [Full Text] [Related]  

  • 6. What is new and/or changing for reimbursement in 2006?
    Merlino DA
    J Nucl Med Technol; 2005 Dec; 33(4):245-6. PubMed ID: 16322127
    [No Abstract]   [Full Text] [Related]  

  • 7. PET/MR imaging consensus paper: a joint paper by the Society of Nuclear Medicine and Molecular Imaging Technologist Section and the Section for Magnetic Resonance Technologists.
    Gilmore CD; Comeau CR; Alessi AM; Blaine M; El Fakhri GN; Hunt JK; Jordan DW; King BJ; Sicignano AJ; Stanley CT; Timpe JT; Wenzel-Lamb N
    J Nucl Med Technol; 2013 Jun; 41(2):108-13. PubMed ID: 23633561
    [No Abstract]   [Full Text] [Related]  

  • 8. [Costing nuclear medicine diagnostic procedures].
    Markou P
    Hell J Nucl Med; 2005; 8(1):27-8. PubMed ID: 15886748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine innovations help (drive) healthcare (benefits).
    Hacker M; Beyer T; Baum RP; Kalemis A; Lammertsma AA; Lewington V; Talbot JN; Verzijlbergen F
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):173-5. PubMed ID: 25416634
    [No Abstract]   [Full Text] [Related]  

  • 10. Will the nuclear medicine industry survive?
    Vermeeren PC
    J Nucl Med; 1995 Jan; 36(1):17N-18N. PubMed ID: 7799072
    [No Abstract]   [Full Text] [Related]  

  • 11. In an era of tough choices, what is your comfort level?
    DePuey EG
    J Nucl Med; 1993 Oct; 34(10):1829-31. PubMed ID: 8280253
    [No Abstract]   [Full Text] [Related]  

  • 12. Nuclear medicine at a crossroads.
    Schelbert HR
    J Nucl Med; 2011 Dec; 52 Suppl 2():10S-5S. PubMed ID: 22144548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear medicine and health care reform.
    Miller L
    J Nucl Med; 1993 Nov; 34(11):32N-34N. PubMed ID: 8229259
    [No Abstract]   [Full Text] [Related]  

  • 14. The opportunities and challenges posed by the rapid growth of diagnostic imaging.
    Rothenberg BM; Korn A
    J Am Coll Radiol; 2005 May; 2(5):407-10. PubMed ID: 17411844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-effectiveness of radiopharmaceuticals in the hospital].
    Fotopoulos A
    Hell J Nucl Med; 2005; 8(1):29. PubMed ID: 15886749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPT code recommendations for nuclear medicine therapy.
    McKusick KA; Wilson M
    J Nucl Med; 2002 Jul; 43(7):27N-28N. PubMed ID: 12109487
    [No Abstract]   [Full Text] [Related]  

  • 17. Coding in nuclear medicine, from examination to tariff: an iterative process.
    Hall M; Beadsmoore C; Allen S; Abbotts N
    Nucl Med Commun; 2016 Nov; 37(11):1113-5. PubMed ID: 27603911
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes and challenges in health insurance.
    Tankersley RL
    Va Dent J; 1992; 69(1):12-5. PubMed ID: 1621419
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reimbursement for alternative medical treatment in the Netherlands, incomprehensible].
    van den Hoogen MW; Popa C; Elving LD; van der Meer JW
    Ned Tijdschr Geneeskd; 2012; 156(6):A4227. PubMed ID: 22316681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of certification and accreditation: A call for daily deeds rather than periodic paper pushing.
    Cohen MC
    J Nucl Cardiol; 2010 Apr; 17(2):342-3. PubMed ID: 20063080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.